DiaMedica Therapeutics Inc.DMACNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average, slight contraction.
Left:
||||
Year-over-year net income growth rate
Latest
-11.96%
↑ 59% above average
Average (39q)
-29.07%
Historical baseline
Range
High:85.16%
Low:-512.34%
CAGR
-5.4%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | -11.96% |
| Q2 2025 | 0.10% |
| Q1 2025 | 2.44% |
| Q4 2024 | -25.92% |
| Q3 2024 | -22.56% |
| Q2 2024 | 0.62% |
| Q1 2024 | 0.19% |
| Q4 2023 | -15.43% |
| Q3 2023 | 0.13% |
| Q2 2023 | 15.08% |
| Q1 2023 | -40.55% |
| Q4 2022 | -22.62% |
| Q3 2022 | 8.90% |
| Q2 2022 | 4.28% |
| Q1 2022 | -8.07% |
| Q4 2021 | 5.91% |
| Q3 2021 | -5.38% |
| Q2 2021 | 9.61% |
| Q1 2021 | 13.76% |
| Q4 2020 | -31.54% |
| Q3 2020 | -29.06% |
| Q2 2020 | -2.02% |
| Q1 2020 | 2.22% |
| Q4 2019 | -1.31% |
| Q3 2019 | 0.85% |
| Q2 2019 | 24.08% |
| Q1 2019 | -206.22% |
| Q4 2018 | -100.92% |
| Q3 2018 | 85.16% |
| Q2 2018 | -512.34% |
| Q1 2018 | 40.86% |
| Q4 2017 | -9.76% |
| Q3 2017 | 16.36% |
| Q2 2017 | 18.14% |
| Q1 2017 | -215.88% |
| Q4 2016 | 56.01% |
| Q3 2016 | -78.30% |
| Q2 2016 | -50.39% |
| Q1 2016 | 26.60% |
| Q4 2015 | -103.73% |